In this study, we explored the down-modulation of AGO2 in breast cancer treated with UA, which led us to understand the increase in the level of PTEN inversely associated with AGO2 expression in inhibiting breast cancer invasiveness. The gene discussed is AGO2; the disease is breast carcinoma.